592. EHR Review: ICANotes

Watch the YouTube video here. Would you rather read the transcript? Click here. In this episode, I conduct a comprehensive evaluation of ICANotes, a legacy electronic health record system updated for modern clinical practice. I evaluate the software specifically...

Long‐term safety and immunogenicity of ABvac40 active immunotherapy in mild cognitive impairment and very mild Alzheimer’s disease: Results from AB1601 phase 2 extension study

Abstract INTRODUCTION ABvac40 is an active immunotherapy targeting Aβ40, the main component of cerebrovascular deposition in Alzheimer’s disease (AD). A 24-month randomized, placebo-controlled phase 2 study (Part A) showed favorable safety and robust...